Preventing Relapse Following Involuntary Smoking Abstinence

NCT01374724 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23000

Last updated 2016-11-01

No results posted yet for this study

Summary

The prevalence of tobacco use in the military is too high. This study is designed to take advantage of the 8.5 weeks of forced tobacco cessation during Basic Military Training and develop effective interventions to prevent tobacco relapse.

Hypotheses or Research Questions:

* Are there differences in the rate of relapse between three groups participating in a tobacco abstinence maintenance intervention?
* Do the tobacco abstinence maintenance interventions delay relapse?

Conditions

  • Smoking
  • Smoking Cessation

Interventions

BEHAVIORAL

Tobacco Use Ban

Airmen are restricted from use tobacco products during Basic Military Training which lasts for 8.5 weeks.

BEHAVIORAL

Tailored Pamphlet

A tailored relapse prevention pamphlet inspired by Forever Free and tailored for use in the United States Air Force.

BEHAVIORAL

Informational Pamphlet

The National Cancer Institute Pamphlet "Clearing the Air" was provided to subjects.

BEHAVIORAL

Relapse Prevention Intervention

A 15 - 30 minute relapse prevention intervention designed to increase motivation to remain tobacco free.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • University of Minnesota

    collaborator OTHER
  • United States Air Force

    collaborator FED
  • University of Tennessee

    lead OTHER

Principal Investigators

  • Robert C. Klesges, Ph.D. · University of Tennessee Health Science Center and St. Jude Childrens' Research Hospital

  • Harry Lando, Ph.D. · University of Minnesota

  • Gerald W. Talcott, Ph.D. · University of Tennessee

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2017-04-30
Completion
2017-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01374724 on ClinicalTrials.gov